In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q2 2023, worth a total value of $53.9m, according to GlobalData’s Deals Database. The $37.7m acquisition of archimica by pi health sciences netherlands was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.

Smarter leaders trust GlobalData

In value terms, M&A activity in Italy remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 40% in Q2 2023 versus the previous quarter and was 40% higher than in Q2 2022.

The top-ranked legal advisorss supporting these M&A deals in Italy Q2 2023 were BonelliErede; CMS Legal Services EEIG; CMS Legal Services EEIG - France with 1, 1, 1 deals respectively.

For further understanding of GlobalData's Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.